EpiCept Corporation Report issue

For profit Phase 1 Phase 2 Phase 4
Founded: Englewood Cliffs NJ United States (1993)
Status: Acquired by Immune Pharmaceuticals (2012) → now United General Ltd (2021)

Organization Overview

First Clinical Trial
2006
NCT00423410
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree